In recent years, considerable progress has been achieved in deciphering the cellular and network functions of GABAergic transmission in the intact developing brain. First, in vivo studies in non-mammalian and mammalian species confirmed the long-held assumption that GABA acts as a mainly depolarizing neurotransmitter at early developmental stages. At the same time, GABAergic transmission was shown to spatiotemporally constrain spontaneous cortical activity, whereas firm evidence for GABAergic excitation in vivo is currently missing. Second, there is a growing body of evidence indicating that depolarizing GABA may contribute to the activity-dependent refinement of neural circuits. Third, alterations in GABA actions have been causally linked to developmental brain disorders and identified as potential targets of timed prophylactic interventions. In this article, we review these major recent findings and argue that both depolarizing and inhibitory GABA actions may be crucial for physiological brain maturation.
Introduction
Inhibition in the adult central nervous system (CNS) is mediated by multiple types of GABAergic interneurons with distinct biophysical properties and connectivity patterns (Tremblay and others 2016) . In addition to preventing runaway excitation of recurrently connected excitatory cells, inhibition is instrumental for multiple basic brain functions such as spike timing, generation of oscillatory activity, control of synaptic plasticity, as well as adjustment of response gain and offset in sensory systems. In order to ensure efficient synaptic inhibition via chloride-permeable GABA A (GABA A Rs) and glycine (GlyRs) receptors, adult CNS neurons actively maintain a low intracellular chloride concentration ([Cl -] in ). This is not the case for most immature neurons (Kirmse and others 2011) . Rather, developing nerve cells typically have a low Cl -extrusion capacity that favors membrane depolarization on Cl -channel opening. A growing body of evidence suggests that depolarizing responses to GABA A R activation are required for the activity-dependent refinement of cortical neural circuits. Accordingly, altered GABA actions might contribute to the pathophysiology of neurodevelopmental disorders.
Neuronal Chloride Extrusion and Synaptic Inhibition
The reversal potential of GABA A R-mediated currents (E GABA ) is determined by the transmembrane concentration gradients of chloride and bicarbonate, which permeate GABA A Rs with a HCO 3 -/Cl -permeability ratio of ~0.2 (Bormann and others 1987; Kaila and Voipio 1987; Zhang and others 1991) . The intracellular HCO 3 -concentration of CNS neurons is considerably higher than expected for a passive distribution, with an estimated reversal potential (E HCO3 ) of −5 to −20 mV. Consequently, at resting membrane potential (V m [Sinning and others 2011] and NCBE/SLC4A10 [Jacobs and others 2008] ) contribute to Cl -homeostasis has yet to be answered (Hübner and Holthoff 2013) .
depolarization. An important implication is that, in order to maintain isoelectric (E GABA = V m ) or even hyperpolarizing (E GABA < V m ) inhibition, neurons need to maintain E Cl at levels more negative than V m . Under such a condition, opening of GABA A Rs would lead to Cl -influx, thereby dissipating the initial electrochemical Cl -gradient. Accordingly, intense activation of GABA A Rs in adult CNS neurons may lead to a fast (on a timescale of seconds or even less) breakdown of the driving force of Cl -, particularly in compartments with a high surface-tovolume ratio (Qian and Sejnowski 1990) . At the same time, intracellular carbonic anhydrase (isoforms 2 and 7) replenishes HCO 3 -by catalyzing the hydration of CO 2 , thereby stabilizing E HCO3 (Ruusuvuori and others 2004; Ruusuvuori and others 2013) . The resulting differential collapse of the electrochemical Cl -and HCO 3 -gradients represents a major mechanism of ionic short-term plasticity (Raimondo and others 2012) and may give rise to GABA A R-mediated depolarization (Kaila and others 1997; Staley and others 1995) , which further promotes channel-dependent Cl -influx. To counteract activity-dependent Cl -loads, most adult CNS neurons are equipped with effective Cl -extrusion mechanisms. Neuronal Cl -extrusion is accomplished by electroneutral K + /Cl -co-transport (Deisz and Lux 1982; Jarolimek and others 1999; Misgeld and others 1986; Thompson and others 1988) , in particular by the co-transporter KCC2 (SLC12A5) (Hübner and others 2001; Rivera and others 1999; Stein and others 2004) . SLC12A5 generates two neuron-specific isoforms, termed KCC2a and KCC2b, of which KCC2b accounts for ~90% of KCC2 protein in the adult cortex (Uvarov and others 2007) . Accordingly, failure of KCC2-mediated Cl -extrusion severely compromises synaptic inhibition. For example, disruption of both KCC2 isoforms led to a pronounced positive shift of E GABA in murine spinal motoneurons, and these mice died immediately after birth due to an insufficient inhibitory control of motoneurons resulting in breathing failure (Hübner and others 2001) . Likewise, conditional deletion of KCC2, but not KCC3, in cerebellar Purkinje neurons prolonged the recovery of [Cl -] in in response to experimentally imposed Cl -loads and induced a positive shift in steady-state E GABA in vitro (Seja and others 2012) . Additionally, mice with a targeted disruption of KCC2b may survive the neonatal period, but eventually died from spontaneous epileptic seizures by the end of the second postnatal week (Uvarov and others 2007; Woo and others 2002) . More recently, KCC2 mutations were identified as a genetic cause of epilepsy in humans (Box 1). In general, other members of the SLC12A family of K + /Cl -co-transporters seem to be of minor importance to Cl -homeostasis in central neurons (Boettger and others 2002; Box 1. KCC2 and Epilepsy.
Based on its essential role in fast synaptic inhibition mutations in SLC12A5 encoding KCC2 have long been predicted in patients with disorders characterized by disturbed neuronal activity such as epilepsy. With a prevalence of roughly 1% worldwide, epilepsy is among the most common neurological diseases. Epilepsy as a disorder on its own is often referred to as idiopathic epilepsy and is thought to be mainly determined by genetic factors. The first evidence that KCC2 is associated with idiopathic epilepsy came from two independent studies: Puskarjov and others (2014b) reported on a small Australian family with partial cosegregation of a rare C-terminal KCC2 variant (R952H) with febrile seizures. In a parallel study, Kahle and others (2014) identified the same R952H variant as well as another C-terminal KCC2 variant, R1049C, in Canadian patients suffering from idiopathic generalized epilepsy. Although the number of the R952H alleles compared to a large control cohort was not significantly increased, the R1049C variant and, in particular, both variants combined clearly revealed a statistical association with idiopathic generalized epilepsy. Recently, two additional studies (Saitsu and others 2016; Stödberg and others 2015) identified recessive lossof-function mutations in patients with early-onset epileptic syndromes characterized by migrating polymorphous focal seizures (epilepsy of infancy with migrating focal seizures [EIMFS] ). There is no doubt that our knowledge of the role of KCC2 in brain disorders will increase with the identification of additional mutations in humans, allowing us to get a better idea about genotype-phenotype correlations.
Chloride Homeostasis during Ontogenesis
A low [Cl -] in maintained by KCC2 represents a specialization of mature CNS neurons. Indeed, it has long been known that the capacity of Cl -extrusion is low in immature neurons and increases during neural development (Cordero-Erausquin and others 2005; Khirug and others 2005; Luhmann and Prince 1991; Zhang and others 1991) . The latter causally depends on an increase in KCC2 expression (Rivera and others 1999; Uvarov and others 2007) , which approximately spreads in a caudorostral manner along the neuraxis (Stein and others 2004) . Additionally, most immature CNS neurons express the co-transporter NKCC1 (SLC12A2), which mediates electroneutral Cl -uptake (Dzhala and others 2005; Pfeffer and others 2009; Sipilä and others 2006; Wang and Kriegstein 2008; Yamada and others 2004) . Some auditory nuclei may be an exception, as we will review later. Collectively, the functional predominance of Cl -import versus export in immature neurons typically renders GABA A R-mediated responses depolarizing in vitro-and potentially excitatory. This finding was confirmed in a substantial number of species, brain areas, and cell types (for reviews, see Ben-Ari and others 2007; Kirmse and others 2011) . Accordingly, in vitro steady-state E GABA is typically more positive than resting V m , and is shifted toward more negative values during further development. Some electrophysiological data suggest that the developmental shift in steady-state E GABA in vitro is already completed before neurons reach their adult Cl -extrusion capacity (CorderoErausquin and others 2005; Luhmann and Prince 1991; Tyzio and others 2008; Zhang and others 1991) . As we will discuss later, this apparent discrepancy may reflect conditions of low Cl -load (as typically the case in vitro) in which E GABA may be hardly affected by a further increase in KCC2 activity. In the rodent neocortex, Cl -extrusion capacity apparently parallels GABAergic synaptogenesis, which is not completed until at the end of the first postnatal month (De Felipe and others 1997; Micheva and Beaulieu 1996) . Likewise, KCC2 transcript levels in the human neocortex display a protracted increase into postnatal life and show high correlation with the expression of the GABAergic presynaptic marker proteins glutamate decarboxylase 65 (GAD2) and vesicular GABA transporter (SLC32A1) (Kang and others 2011 (Kolbaev and others 2011b) , the same reasoning complicates extrapolations of the steady-state E GABA measured in vitro to the in vivo situation. In fact, electrophysiological data point to a considerably higher frequency of GABAergic postsynaptic currents in cortical neurons in vivo than in acute slices (Valeeva and others 2016) . This could contribute to g Cl -dependent E GABA shifts, especially if the Cl -uptake capacity was low (Achilles and others 2007) .
Does GABA act as a depolarizing neurotransmitter in the intact brain? This question long remained unresolved, thereby paving the way for a scientific controversy during recent years (for review, see Kirmse and others 2011 transients that strongly depended on NKCC1. Additional electrophysiological recordings provided direct evidence for mainly depolarizing GABA effects ( Figure 1A ). Of particular interest, neither puff-applied nor synaptically released GABA induced action potential firing in immature layer 2/3 cells (Kirmse and others 2015) , as opposed to previous in vitro data (Kirmse and others 2010) , suggesting that GABAergic depolarization in vivo is mainly operative in the sub-threshold V m range ( Figure 1B ). An open question is whether E GABA in vivo is uniformly distributed within cells. Obviously, non-uniform E GABA distributions would profoundly affect postsynaptic responses induced by subtypes of interneurons with different axonal target specificities. In this context, the advent of refined Morita and others 2006) . It turned out that GABAergic depolarization might either facilitate or inhibit neuronal firing, depending on a number of timevariant parameters, including resting V m , E GABA , the threshold of action-potential firing as well as the spatial and temporal profiles of synaptic inputs. In spite of the mere biophysical possibilities, one important question is whether, in the intact brain, endogenous spatiotemporal patterns of GABA A R activation favor either excitatory or inhibitory actions, or whether both excitatory and inhibitory effects occur to a substantial degree. To address this question, Valeeva and colleagues optogenetically activated GABAergic interneurons by channelrhodopsin-2 while simultaneously monitoring excitatory postsynaptic currents (EPSCs) using whole-cell recordings in the hippocampus or neocortex (Valeeva and others 2016) (Table  2) . In their study, EPSCs served as an indirect and noninvasive readout of the firing of presynaptic glutamatergic cells. EPSC frequency was profoundly increased by a 500-ms stimulation of GABAergic interneurons in acute slices at P2-8, but was decreased by optogenetic GABA release in head-restrained mice under urethane or ketamine-xylazine anesthesia at P3-9. While the origin of this discrepancy remains unresolved, g Cl -dependent differences in E GABA between in vitro and in vivo models represent a plausible explanation. These data suggest that GABAergic transmission in vivo may profoundly inhibit neonatal cortical and hippocampal networks despite its predominantly depolarizing nature (Kirmse and others 2015; Tyzio and others 2008) . However, since EPSC frequency reflects the behavior of many presynaptic cells (with multiple connectivity patterns), excitatory GABA actions in subsets of cells cannot be excluded.
Prior to eye opening, cortical networks operate in a dense coding regime in which discrete events, separated by relatively long quiescent periods, synchronize large local cell populations. At this age, so-called spindle bursts are a prototypical activity pattern, that is, spindle-shaped local-field potential oscillations in the theta-to-beta (~4-25 Hz) spectral range, which have been detected in multiple neocortical areas (Hanganu and others 2006; Khazipov and others 2004; Yang and others 2009 ). Widefield and three-dimensional Ca 2+ imaging in the occipital cortex revealed that spindle bursts involve a column-like activation of cortical glutamatergic neurons due to distinct horizontal confinement (Kirmse and others 2015; Kummer and others 2016) . The frequency and spatial extent of Ca 2+ clusters/spindle bursts during the first postnatal week were unaffected by local pharmacological inhibition of NKCC1 using bumetanide (Kirmse and others 2015; Minlebaev and others 2007) , as were visually evoked responses at P9-11 (Colonnese and others 2010) ( Table 2 ). Of note, local application techniques as used in these studies circumvent the blood-brain barrier, which exhibits a particularly low permeability for bumetanide (Puskarjov and others 2014a) . Collectively, available data support the notion that NKCC1-dependent GABAergic depolarization is not essential for driving the generation of cortical spindle bursts. However, the recording methods used (extracellular recordings, widefield Ca 2+ imaging) do not allow spatiotemporal single-cellular dynamics to be assessed. For this reason, modulatory NKCC1 effects cannot be excluded at this level, but available data indicate that spindle bursts do not represent the in vivo 
E GABA = reversal potential of GABA A R-mediated currents; DF GABA = driving force for GABA A R-mediated currents; RMP = resting membrane potential; d = day; P = postnatal day; 2P = two-photon; CP = cortical plate. counterpart of so-called giant depolarizing potentials, a principal form of coordinated network activity in hippocampal and cortical slices, which, indeed, strongly depends on NKCC1 (Allene and others 2008; Pfeffer and others 2009; Rheims and others 2008) . However, systemic application of the NKCC1/NKCC2 inhibitor bumetanide was reported to reversibly abolish hippocampal sharp waves in non-anesthetized neonatal rat pups (Sipilä and others 2006) . Whether the observation reflects an attenuation of GABAergic depolarization in hippocampal neurons or indirect effects, for instance in circumventricular organs (not shielded by the blood-brain barrier) or in the periphery, has yet to be clarified. In an independent study, twice daily systemic administration of bumetanide from the day of birth onward did not affect the generation of either cortical spindle bursts or hippocampal beta oscillations and sharp waves in neonatal mice (Marguet and others 2015) . In principle, GABA may synchronize neuronal populations by either inhibition or excitation. Considering that interference with GABA A Rs will hardly allow direct conclusions on single-cellular GABA actions to be drawn, local block of GABA A Rs was found to disinhibit the generation of Ca 2+ clusters/spindle bursts in both the somatosensory (Figure 2 ) and the occipital (Figure 3 ) cortex, whereas allosteric GABA A R activation reduced their horizontal extent (Kirmse and others 2015; Minlebaev and others 2007) (Table 2 ). Similar observations regarding visually evoked responses were made during the second postnatal week (Colonnese and others 2010) . These findings contrast with previous in vitro data from acute brain slices, suggesting an inhibition of network activity following GABA A R block (Conhaim and others 2011; Garaschuk and others 2000) . Additionally, GABA A Rdependent transmission seems to be dispensable for the generation of early gamma oscillations (EGOs, a transient activity pattern found in layer 4 of the neonatal barrel cortex) until postnatal day (P) ~4 (Minlebaev and others 2011) . Only at the end of the first postnatal week were inhibitory postsynaptic currents (IPSCs) engaged in EGOs, and EGO generation was effectively inhibited by GABA A R block (Minlebaev and others 2011) .
In summary, an accumulating body of evidence indicates that GABA may act as a depolarizing and inhibitory neurotransmitter in developing cortical areas whereas firm evidence supporting GABAergic excitation in vivo is currently missing.
GABA and the Auditory System
Inhibitory neurotransmission via GABA or glycine also plays a substantial role in brainstem circuits like the auditory pathway. Here inhibitory circuits are essential for the computation of interaural level and interaural time and hence sound localization. As their basic functions are known quite well (Friauf and others 2011; Milenkovic and Rubsamen 2011) , we will describe how inhibition evolves during development of subcortical circuits for the auditory system. Sound waves are transformed into electrical signals by hair cells in the organ of Corti. The information proceeds from here to spiral ganglion neurons and via the cochlear nerve to the different auditory nuclei to the cortex where the signals are perceived as sound. Importantly, auditory afferents are tonotopically organized starting with high frequencies transduced at the base of the cochlea, and low frequencies transduced at the apex. This segregation of high and low frequencies persists throughout the auditory pathway. Brainstem nuclei include the cochlear nuclei (CN), which receive afferent input from ipsilateral spiral ganglion fibers. Many fibers from the CN then cross to the superior olive of the contralateral brain stem, which is divided into three primary nuclei, the medial superior olive (MSO), the lateral superior olive (LSO), and the medial nucleus of the trapezoid body (MNTB). Ascending fibers stop in the inferior colliculus in the midbrain and the medial geniculate body in the thalamus, before reaching the cortex.
The excitatory input from the spiral ganglion neurons is conveyed to the CN via auditory nerve fibers. The spherical bushy cells in the anteroventral part of the CN integrate excitatory inputs from some auditory nerve fibers and acoustically driven inhibitory input to localize the source of an acoustic cue. In these cells, the shift from depolarization to hyperpolarization occurs at the end of the first postnatal week, that is, before hearing onset. Pharmacological studies on gerbil spherical bushy cells suggest that Cl -is accumulated via NKCC1 at P3-5. The low [Cl -] in is established during the second postnatal week by downregulation of NKCC1 and concomitant Cl -extrusion via KCC2 (Witte and others 2014) . Globular bushy cells represent another type of second-order neuron in the CN and provide excitatory input to the contralateral MNTB. In globular bushy cells a hyperpolarizing response to glycine was reported at P9-11. Surprisingly, however, their synaptic terminals at MNTB neurons maintain an E Cl > V m even after hearing onset. Thus the activation of presynaptic GABA and glycine receptors supports the release of glutamate by the calyx of Held (Milenkovic and Rubsamen 2011) .
The MSO is thought to help locate the angle to the left or right where the sound source is located. Therefore, MSO neurons receive excitatory input from spherical bushy cells of both sides to compare the arrival time of convergent excitatory input (Goldberg and Brown 1969; Yin and Chan 1990) . A shift from depolarization to hyperpolarization in MSO neurons occurs between P5 and P9, though KCC2 is already expressed around P0, suggesting an activation by post-translational modification at that time (Lohrke and others 2005) . The GABAdependent input from MNTB neurons in rats younger than P6 is gradually replaced by glycine (Smith and others 2000) . In addition, MSO neurons also receive inhibitory input from the lateral nucleus of the trapezoid body (Grothe and Sanes 1993) . The projections of the MSO terminate densely in the ipsilateral central nucleus of the inferior colliculus.
The LSO is believed to be involved in measuring the difference in sound intensity between the ears. Therefore, the LSO neurons integrate excitatory input from spherical bushy cells in the ipsilateral CN and inhibitory input from the MNTB, which is driven by excitatory input from globular bushy cells in the contralateral CN. Thus, the LSO receives excitatory input from the ipsilateral ear and inhibitory input from the contralateral ear. LSO neurons project bilaterally to the central nucleus of the inferior colliculus in the midbrain. Ipsilateral projections are primarily glycinergic, and the contralateral projections glutamatergic. Before hearing onset, the depolarizing response of LSO neurons to MNTB input can even trigger action potentials (Kullmann and Kandler 2001) and increase Ca 2+ concentration suggesting that MNTB-dependent Ca 2+ responses contribute to activity-dependent synapse reorganization (Friauf and others 2011) . The shift from depolarization to hyperpolarization occurs between P4 and P6 (Ehrlich and others 1999) . Interestingly, the shift is not paralleled by an increase in KCC2 protein level, implying that KCC2 is activated via phosphorylation at this time point. The mechanisms that contribute to Cl -loading are not known since NKCC1 is not expressed (Balakrishnan and others 2003) .
Like in the LSO, there is an age-dependent shift in GABAergic to glycinergic transmission in the MNTB. MNTB neurons provide the major glycinergic input to a number of nuclei such as the MSO and the LSO. In MNTB neurons, the shift from depolarization to hyperpolarization occurs late between P10 and P14 (Awatramani and others 2005) .
These different examples illustrate that the molecular mechanisms that accumulate Cl -in immature auditory neurons are largely unclear. In contrast to other brain regions (Pfeffer and others 2009), NKCC1 does not appear to play a major role in some parts of the auditory pathway as, for example, in the LSO, where its expression pattern does not correlate with a depolarizing Cl -gradient. Although it was suggested that the anion-exchanger AE3 might serve as the main Cl -loader in LSO neurons, AE3 has been excluded, since LSO neurons in AE3 knockout mice (Hentschke and others 2006) revealed normal E Cl values at P2-4 (Friauf and others 2011). In addition to the expression of KCC2, there is also clear evidence for additional requirements for the maturation of inhibitory transmission like the activation of KCC2 by post-translational mechanisms. Moreover, it is intriguing why the shift from depolarization to hyperpolarization occurs at different time points in different auditory nuclei. Since the maturation of the auditory system was proposed to be promoted by spontaneous prehearing activity (Tritsch and others 2007) , it will be interesting to address whether this also applies for the shift in [Cl - ] in .
Developmental Functions of Depolarizing GABA In Vivo
Are there specific requirements for depolarizing rather than hyperpolarizing effects of GABA during brain development? Despite the teleological nature of the question, several lines of evidence suggest that this may indeed be the case (see below). However, ample evidence confirms that depolarizing GABA does mediate inhibition rather than excitation in the rodent neonatal cortex in vivo. Therefore, an alternative scenario could be the following: (Houston and others 2009; Pitt and others 2008) , thereby affecting the spatiotemporal integration of synaptic inputs. (5) In cerebellar cultures, [Cl - ] in was additionally found to modulate the expression of GABA A R subunits responsible for phasic and tonic inhibition-independent of GABA A Rdependent signaling (Succol and others 2012) . However, it remains currently unknown whether a similar mechanism is functional in the intact brain.
While this list is certainly incomplete, several lines of experimental evidence suggest that the GABA-dependent modulation of Ca 2+ signaling pathways is of developmental importance. For example, the block of NKCC1 or the buffering of intracellular Ca 2+ reduced the multidirectional tangential migration of GABAergic interneurons in the cortical marginal zone in vivo (Inada and others 2011) . Furthermore, the repetitive release of GABA by two-photon uncaging onto dendrites of neonatal layer 2/3 pyramidal cells was found to induce GABAergic and glutamatergic synapse formation in slice cultures (Oh and others 2016) . This effect occurred within minutes, required activation of GABA A Rs and was dependent on NKCC1 and Ca 2+ influx via L-and T-type VGCCs. Of note, the synaptogenic effect of GABA was also observed in vivo at P5-13 (Oh and others 2016) . The latter finding suggests that GABA may evoke local dendritic Ca 2+ transients despite the fact that GABAergic depolarization is largely incapable of eliciting action potentials in neonatal layer 2/3 neurons (Kirmse and others 2015) . In addition to promoting de novo synaptogenesis, depolarizing GABA may be intimately involved in aiding plasticity at established synapses. For example, GABA-dependent depolarization in vitro enhanced NMDAR-dependent currents by reducing their voltagedependent Mg 2+ block (Chancey and others 2013; Leinekugel and others 1997) . Consequently, GABAergic synapses may serve to promote NMDAR-dependent forms of plasticity during early neuronal development. Because of the sole presence of NMDARs, many immature glutamatergic contacts are electrically "silent" at normal resting V m . Pairing glutamate release with imposed postsynaptic depolarization is suited to recruit AMPA receptors (AMPAR) to these synapses (Durand and others 1996; Isaac and others 1995) .
Though not yet demonstrated in vivo, GABAergic synapses are potentially sufficient to provide the postsynaptic depolarization required for such "synaptic unsilencing" (Chancey and others 2013) . In line with this view, RNA interference knock-down of NKCC1 in the somatosensory cortex by in utero electroporation did not only attenuate depolarizing GABA actions, but also dramatically reduced the density of dendritic spines and the frequency of AMPAR-mediated miniature EPSCs (mEPSCs) in juvenile mice (Wang and Kriegstein 2008) . These synaptic deficits were rescued by overexpression of a voltage-independent NMDAR variant pointing to a causal synergy between GABA A Rs and NMDARs during glutamatergic synaptogenesis in vivo. Moreover, daily intraperitoneal administration from embryonic day 15 to P7 of the NKCC1/NKCC2 inhibitor bumetanide induced similarly profound impairments of glutamatergic transmission in the rat neocortex (Wang and Kriegstein 2011) . However, the same treatment did not disturb glutamatergic synaptogenesis if confined to the postnatal period (Deidda and others 2015a; Wang and Kriegstein 2011) . A reduction in mEPSC amplitude and frequency was also observed in hippocampal pyramidal cells of NKCC1 knock-out mice. In this model, however, deficits were much more moderate, not accompanied by structural alterations and disappeared by P15 (Pfeffer and others 2009) . Compelling evidence for a distinct developmental function of subthreshold GABAergic depolarization has recently been obtained in the optic tectum of Xenopus laevis tadpoles at the onset of vision (van Rheede and others 2015) . At a time when sensory stimulation failed to evoke action potentials in many tectal neurons, brief visual experience was found to convert sub-into suprathreshold responses within minutes. This sensory-driven plasticity resulted from a selective strengthening of AMPAR-dependent EPSCs and was restricted to neurons that were depolarized by GABA (Figure 4) . Additionally, the conversion into visually spiking neurons was abolished by local pharmacological inhibition of NKCC1 or NMDARs. This study confirmed that subthreshold depolarizing GABA may contribute to the maturation of sensory circuits in vivo (van Rheede and others 2015) .
Whether the proper development of GABAergic synapses depends on depolarizing GABA actions remains controversial, as published studies yielded largely inconsistent results (Deidda and others 2015a; Pfeffer and others 2009; Wang and Kriegstein 2008; Wang and Kriegstein 2011) . Likewise, it currently remains unclear whether gross dendritic maturation depends on GABAergic depolarization in early life. Whereas CA1 pyramidal cells of conventional NKCC1 knock-out mice developed normal dendritic arborizations and spine densities (Pfeffer and others 2009), shRNA-mediated knock-down of NKCC1 profoundly impaired dendritic maturation in neocortical neurons (Wang and Kriegstein 2008) . Strongly reduced dendritic branching was also observed in layer 2/3 neurons in which GABAergic depolarization was abolished by premature overexpression of KCC2 (Cancedda and others 2007) . However, this result could not be validated in a subsequent study using similar techniques (Fiumelli and others 2013) . Of note, KCC2 is thought to contribute to the structural development of dendritic spines by interactions with the cytoskeleton, that is, independent of Cl -transport (Fiumelli and others 2013; Li and others 2007) . Clearly, further investigations using refined manipulation methods with high spatial and temporal specificity are necessary to reveal the causal impact of GABAergic depolarization to various aspects of brain development in vivo.
Developmental GABAergic Signaling as Therapeutic and Prophylactic Target
In addition to E Cl , GABA A R-mediated ion flux is also governed by subunit composition, receptor density, and GABA release, which are known to undergo developmental changes (Kilb 2012) . GABA has been shown to be one of the earliest neurotransmitters to be present in the developing brain. Besides its established role in controlling cellular and network excitability, as discussed before, it can have multiple functions including regulating progenitor proliferation, influencing the migration and maturation of newborn neurons (for review, see Wang and Kriegstein 2009) , and regulating cortical synaptogenesis (Oh and others 2016) . As a consequence, perturbations in GABA actions, caused by either intrinsic/genetic factors (e.g., GABA A R subunit gene mutations) or external insults (e.g., hypoxia) that are not compensated for by homeostatic mechanisms (Turrigiano and Nelson 2004) , may lead to neurological conditions such as epilepsy, cognitive deficits, or mental disorders (Ramamoorthi and Lin 2011) . With respect to the development of the cerebral cortex, it is, for example, well established that the time course of maturation of GABAergic signaling and a proper excitatory-inhibitory balance play an essential role in cortical sensory development. This role of GABAergic signaling is best characterized in the visual system, in which a block of external inputs by visual deprivation during specific critical periods induces irreversibly altered visual processing in the adult (Hensch 2004; Katagiri and others 2007; Levelt and Hubener 2012) . If such critical periods also play a role in disease etiology, common neuropathologies such as epilepsy, attention deficit hyperactivity disorder (ADHD), or autism spectrum disorder (ASD) may be prevented by therapeutic interventions targeted to the modulation of GABA action and vulnerable periods of brain development. From the perspective of therapeutic safety, the modification of E Cl appears to be an attractive strategy because it would attenuate GABA A R-mediated depolarization and, when co-applied with GABA A R mimetics, increase shunting inhibition (Dzhala and others 2008) . As E Cl can be predicted based on intra-and extracellular ion concentrations (Kaila and others 2014) , lower [Cl - ] in in neurons that express functional NKCC1 or KCC2 transporters can be achieved by a reduction in NKCC1 or an increase in KCC2 activity (Löscher and others 2013) . Alternatively, or in addition to that, sodium-independent or sodium-dependent anion-exchanger activities such as those of AE3 or NDCBE might be targeted to lower [Cl - ] in even further (Hübner and Holthoff 2013) by, for example, blocking the intracellular generation of HCO 3 -via carbonic anhydrase inhibition.
Developmental changes in GABA signaling occur physiologically and under inherited or acquired pathophysiological conditions. Mutations in GABA A R subunit genes are linked to specific epilepsy syndromes whose distinct clinical phenotypes depend, among other things, on the nature of the mutation, the neuron types affected, and the subcellular localization of the affected subunit (Macdonald and others 2012; Miles and others 2012) . The most frequent causes of acquired changes in developmental GABA signaling that disrupt cortical circuit formation and predispose to epilepsy occur secondary to hypoxic-ischemic insults, trauma, infections, or exposure to noxious substances such as medications, drugs, or alcohol. The resulting changes affecting cellular and network excitability include altered GABA A R subunit expression, loss or delayed insertion of interneurons (Deidda and others 2015b; Duarte and others 2013; Silva and others 2013; Skorput and others 2015) , and alterations in KCC2 and NKCC1 transporter activities or expression (Tang and others 2016) . The latter changes, which may result in a more positive E Cl , could provide an explanation as to why barbiturates and other GABA mimetics, although still commonly used in clinical practice, are often not efficacious in controlling seizures following neonatal insults, do not improve the long-term outcome (Booth and Evans 2004) , and have a questionable prophylactic safety (Evans and others 2007) .
Recent findings in rodents suggest that, during birth, E Cl undergoes a rapid and transient hyperpolarizing shift induced by oxytocin (Khazipov and others 2008; Tyzio and others 2006) -and possibly vasopressin (Spoljaric and others 2016)-as an adaptive and protective mechanism facilitating the rapid transition to extrauterine life and resulting in a more mature GABA action. This fast oxytocin effect on E Cl is likely to be mediated by a decrease in NKCC1 activity (Khazipov and others 2008; Tyzio and others 2006) . In addition, oxytocin signaling via the oxytocin receptor appears to be modulating longterm KCC2 activity (Leonzino and others 2016) . When oxytocin signaling in the mother was pharmacologically blocked by the oxytocin receptor antagonist SSR126768A, CA3 pyramidal neurons had a persistently increased E Cl and a disturbed excitation-inhibition balance (Tyzio and others 2014) . In the same study, using two experimental ASD models, pharmacological block of NKCC1 by application of bumetanide to the mother before parturition normalized E Cl in the offspring (Tyzio and others 2014) . The prophylactic targeting of NKCC1 or KCC2 activities timed to specific vulnerable periods of brain development in patients who are at an increased risk of developing long-term neurological disabilities (e.g., very premature newborns, newborns after perinatal hypoxia) may thus be crucial to disease prevention. This concept was recently tested in a mouse model of K V 7 encephalopathy in which the activity of neuronal K V 7 voltage-gated potassium channels, also known as M-channels, was suppressed by a dominant-negative K V 7.2 transgene. Prophylactic treatment with bumetanide aimed at a vulnerable neonatal period-previously identified using a conditional transgenic approach (Peters and others 2005)-prevented epileptogenesis, neuroinflammation, and behavioral abnormalities ( Figure 5 ) (Marguet and others 2015) . These beneficial effects of targeting E Cl implicate early GABA A R-mediated activity in the pathophysiology of the K V 7 epileptic encephalopathy model and suggest that attenuating intracellular Cl -accumulation via NKCC1 blockade, or potentially via KCC2 activation (Puskarjov and others 2014a), can be protective. As both hypoxia and brain trauma can also raise [Cl -] in and shift E GABA (Huberfeld and others 2007; Miles and others 2012) , the modification of Cl -balance may be a promising therapeutic strategy for neurodevelopmental diseases.
Bumetanide and other existing NKCC1 inhibitors are, however, suboptimal because of their unfavorable pharmacokinetic properties such as limited penetration of the blood-brain barrier, fast metabolization, and lack of target specificity (Löscher and others 2013; Puskarjov and others 2014a; Töpfer and others 2014) . Bumetanide treatment for extended pre-and postnatal periods impaired brain development in mice (Wang and Kriegstein 2011) , and potential side effects such as ototoxicity (Pressler and others 2015) need to be taken into account as well. Despite these caveats, bumetanide treatment in adult mice normalized E Cl , synaptic plasticity, and hippocampus-dependent memory in a model of Down syndrome (Deidda and others 2015b) and improved ASD symptoms in adolescents and young adults (Hadjikhani and others 2015; Lemonnier and others 2012) . While in these studies the bumetanide effect was limited to the time of administration and reversible, prophylactic treatment with bumetanide during vulnerable developmental periods in the ASD and epilepsy models described above had life-long beneficial effects on the offspring (Marguet and others 2015; Tyzio and others 2014) .
In summary, as experimental evidence is accumulating that maintenance of Cl -homeostasis plays an essential role in many neurodevelopmental disorders, the development of improved drugs blocking Cl -influx or enhancing Cl -extrusion represents a promising avenue for the prevention or optimized treatment of a wide range of neurological and psychiatric conditions.
Concluding Remarks
While it is evident that additional studies are required to obtain a coherent picture of GABAergic signaling in the intact immature brain, considerable progress has been achieved in recent years. In particular, the application of in vivo models for manipulating and analyzing GABAergic transmission revealed novel insights that could not be gained using in vitro preparations. Refined techniques including optical, optogenetic, and quantitative computational approaches may help further deepen our understanding of the cell-specific and subcellular effects of GABA at multiple developmental stages. A mechanistic understanding of GABAergic transmission during brain maturation is required in order to identify new prophylactic and therapeutic targets for various developmental brain disorders. 
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